Implementation Feasibility and Clinical Utility of Phenomapping in Dilated and Hypokinetic Non-dilated Non-ischemic Cardiomyopathy
Aims Despite phenotypic heterogeneity, the management of idiopathic non-ischemic cardiomyopathy (NICM) remains generalized and dominantly guided by left ventricular (LV) ejection fraction (EF) and NYHA class. We aimed to develop a point-of-service phenomapping pathway for dilated cardiomyopathy (DCM) and hypokinetic non-dilated cardiomyopathy (HNDC) at time of CMR imaging leveraging the integration of i) patient self-reported health status, ii) imaging phenotype, and the iii) electronic health record (EHR). Methods and results 1,355 patients (752 DCM and 603 HNDC) were followed for the composite MACE outcome of mortality, heart failure hospitalization or ventricular arrhythmia. K-means clustering was independently applied to DCM and HNDC derivation cohorts using 55 routinely captured features (16 patient-reported health variables, 19 CMR-derived, 14 EHR-derived, and 6 combined features), identifying three phenogroups in each cohort. Over a median of 3.9 and 3.7 years, 145 DCM patients (22%) and 65 HNDC patients (13%), respectively, experienced MACE. Adjusting for age, sex, NYHA class, and LV EF, phenogroup membership was independently associated with future outcomes. In DCM, the adjusted HR (95% CI) of phenogroups 2 and 3 versus Phenogroup 1 were 2.8 (1.6-4.8) and 3.5 (1.9-6.5), respectively (p<0.001 for both). In HNDC, Phenogroup 3 demonstrated an adjusted HR of 4.2 (1.7-10.2; p=0.001) versus Phenogroup 1. Prospective phenogroup assignment was enabled by a decision tree-classifier and validated in a temporal hold-out cohort. Conclusion Phenomapping delivers incremental value to LVEF and NYHA for identification of high-risk NICM patients. These findings support value from standardized, point-of-service data integration for the delivery of phenomics-driven personalized care.
Authors
- Justin J. Tse (ORCID: https://orcid.org/0000-0002-5107-5884)
- Nowell Mark Fine (ORCID: https://orcid.org/0000-0002-6546-6587)
- Sandra M. Rivest (ORCID: https://orcid.org/0009-0007-4953-0407)
- Steven Dykstra (ORCID: https://orcid.org/0000-0001-9042-535X)
- Carmen P. Lydell
- Ahmed Abdelhaleem (ORCID: https://orcid.org/0000-0002-9047-6234)
- Fereshteh Hasanzadeh (ORCID: https://orcid.org/0009-0009-7369-3526)
- Andrew G. Howarth (ORCID: https://orcid.org/0000-0003-3359-4573)
- Louis R. Kolman
- James A. White (ORCID: https://orcid.org/0000-0002-5297-4507)
- Jacqueline A. Flewitt (ORCID: https://orcid.org/0000-0001-7985-9907)
- Dina Labib (ORCID: https://orcid.org/0000-0001-7108-8554)
- Yifan Wang (ORCID: https://orcid.org/0009-0005-7484-6759)
- R J H Miller
- Yuanchao Feng
Institutions
- Alberta Health Services (CA)
- Cairo University (EG)
- University of Ottawa (CA)
- University of Calgary (CA)
- Cairo University hospitals (EG)
- Saint Alphonsus Medical Center (US)
- Libin Cardiovascular Institute of Alberta (CA)
Publication Details
- Journal
- European Heart Journal - Cardiovascular Imaging
- Published
- 2026-11-19
- DOI
- https://doi.org/10.1093/ehjci/jeag329
- Primary Topic
- Cardiomyopathy and Myosin Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00